CHE (STOCKS)
Chemed Corporation
$423.490000
+4.180000 (+1.00%)
Prev close: $419.310000
Company Information
- Exchange
- XNYS
- Sector
- Health Services
- Industry
- Hospital/Nursing Management
- CEO
- Kevin J. McNamara
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $5,628.35M
- Employees
- 15,695
- P/E (TTM)
- 22.85
- P/B (TTM)
- 6.54
- Dividend Yield
- 57.24%
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
2
Buy
4
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$5.65 | $5.36 | +0.2945 | +5.50% |
|
Dec 2025 (Q4)
|
$6.42 | $7.14 | -0.7182 | -10.06% |
|
Sep 2025 (Q3)
|
$5.27 | $5.43 | -0.1562 | -2.88% |
|
Jun 2025 (Q2)
|
$4.27 | $5.03 | -0.7598 | -15.11% |
Financial Statements
| Revenues | $2.54B |
| Benefits Costs and Expenses | $2.19B |
| Cost Of Revenue | $1.72B |
| Costs And Expenses | $2.21B |
| Gross Profit | $822.54M |
| Nonoperating Income/Loss | $22.81M |
| Operating Expenses | $2.21B |
| Selling, General, and Administrative Expenses | $425.92M |
| Other Operating Expenses | $1.79B |
| Operating Income/Loss | $328.07M |
| Income/Loss From Continuing Operations After Tax | $259.78M |
| Income/Loss From Continuing Operations Before Tax | $348.94M |
| Income Tax Expense/Benefit | $89.16M |
| Income Tax Expense/Benefit, Deferred | $3.49M |
| Interest Expense, Operating | $1.93M |
| Net Income/Loss | $259.78M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $259.78M |
| Net Income/Loss Available To Common Stockholders, Basic | $259.78M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $18.36 |
| Diluted Earnings Per Share | $18.32 |
| Basic Average Shares | 42,523,000 |
| Diluted Average Shares | 42,642,000 |
| Common Stock Dividends | $2.30 |
| Assets | $1.54B |
| Current Assets | $274.06M |
| Inventory | $7.21M |
| Other Current Assets | $266.86M |
| Noncurrent Assets | $1.26B |
| Fixed Assets | $207.73M |
| Intangible Assets | $80.42M |
| Other Non-current Assets | $973.60M |
| Liabilities | $687.82M |
| Current Liabilities | $321.42M |
| Accounts Payable | $65.70M |
| Wages | $62.75M |
| Other Current Liabilities | $192.97M |
| Noncurrent Liabilities | $366.41M |
| Equity | $847.99M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $847.99M |
| Liabilities And Equity | $1.54B |
| Net Cash Flow From Operating Activities | $443.75M |
| Net Cash Flow From Operating Activities, Continuing | $443.75M |
| Net Cash Flow From Investing Activities | -$83.46M |
| Net Cash Flow From Investing Activities, Continuing | -$83.46M |
| Net Cash Flow From Financing Activities | -$517.32M |
| Net Cash Flow From Financing Activities, Continuing | -$517.32M |
| Net Cash Flow | -$157.03M |
| Net Cash Flow, Continuing | -$157.03M |
| Comprehensive Income/Loss | $259.78M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $259.78M |
| Other Comprehensive Income/Loss | $0.00 |